WangXQZhangHJQuinnMJ. Fetal Hypertension and the “Barker Hypothesis”. Angiology. 2019;71(1):92–3.
2.
Lane-CordovaADKhanSSGrobmanWAGreenlandPShahSJ. Long-term cardiovascular risks associated with adverse pregnancy outcomes: JACC review topic of the week. J Am Coll Cardiol. 2019;73(16):2106–16.
3.
DorotaDKBogdanKGMieczyslawGBozenaLGJanO. The concentrations of markers of bone turnover in normal pregnancy and preeclampsia. Hypertens Pregnancy. 2012;31(1):166–76.
4.
ShaarawyMZakiSRamziAMSalemMEEl-MinawiAM. Feto-maternal bone remodeling in normal pregnancy and preeclampsia. J Soc Gynecol Investig. 2005;12(5):343–8.
5.
BrianaDDMalamitsi-PuchnerA. Adipocytokines in normal and complicated pregnancies. Reprod Sci. 2009;16(10):921–37.
6.
BrianaDDBoutsikouMBoutsikouTMalamitsi-PuchnerA. Relationships between maternal novel adipocytokines and bone biomarkers in complicated by gestational hypertensive disorders and normal pregnancies. J Matern Fetal Neonatal Med. 2013;26(12):1219–22.
7.
MusialowskaDZbrochEKoc-ZorawskaEMusialowskiPMalyszkoJ. Endocan concentration in patients with primary hypertension. Angiology. 2018;69(6):483–9.
8.
BaltaSMikhailidisDPDemirkolS, et al.Endocan—a novel inflammatory indicator in newly diagnosed patients with hypertension: a pilot study. Angiology. 2014;65(9):773–7.
9.
BaltaSMikhailidisDPDemirkolSOzturkCCelikTIyisoyA. Endocan: a novel inflammatory indicator in cardiovascular disease?Atherosclerosis. 2015;243(1):339–43.
10.
CelikMSokmenESivriSUcarCNarRErerM. The relationship between serum endocan level and aortic elastic properties in patients with newly diagnosed essential hypertension. Angiology. 2019;70(7):662–8.
11.
MazidiMTothPPBanachM. C-reactive protein is associated with prevalence of the metabolic syndrome, hypertension, and diabetes mellitus in us adults. Angiology. 2018;69(5):438–42.
